the aid library

LIST OPTIONS

Filter

7584

Download (537)

View PDF (580)

Psychoses

World Health Organization WHO (2015) C_WHO

PSY supporting material • Person stories • Case scenarios • Role plays • Multiple choice questions • Video links

Download (745)

View PDF (1211)

Let our Actions Count. Reflections on NSP 2012-2016 and moving forward to NSP 2017-2022

South African National AIDS Council (2017) C1

Download (769)

View PDF (982)

Thailand: Disaster Management Reference Handbook

Center for Excellence in Disaster Management and Humanitarian Assistance (2022) C1

Thailand is exposed to flooding, landslides, drought, earthquakes, tsunamis, heat waves, forest fires, and epidemics. Thailand is also exposed to technological hazards such as chemical accidents. Flooding is the natural hazard with the most significant impact on human life, livelihoods, and the econ... more

Download (362)

View PDF (490)

My Child: 2 to 5 years

Health Service Excecutive HSE Ireland (2021) CC

My Child: 2 to 5 years is a free book from the HSE with advice to help you and your child from age 2 to 5. This edition has text in English with Arabic translation.

Download (481)

View PDF (362)

Guidelines for the prevention, surveillance and management of COVID-19 infection among health care workers in Zimbabwe

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The Guidelines for the Prevention, Surveillance and Management of COVID-19 Infection amongst Health Care Workers (HCW) in Zimbabwe were developed to prevent, detect and manage HCW COVID-19 infection, an emerging pandemic affecting the whole world. The HCW is at the fore front of this pandemic, thus ... more

Download (13692)

View PDF (5825)

Diarrhoea Treatment Guidelines
recommended

The MOST Project USAID (2005) C_WHO

The WHO page addresses diarrhoeal diseases, one of the leading causes of death among children under five, which can be prevented through clean water, improved hygiene, and vaccinations. It emphasizes the importance of oral rehydration solutions (ORS) and zinc supplementation for treatment, as well a... more

Download (392)

View PDF (620)

Adaptación basada en los ecosistemas urbanos reverdecimiento de las ciudades para luchar contra el cambio climático

UN Enivronemnt Programme UNEP (2022) CC

Nota inormative 8

Download (326)

View PDF (561)

War and Peace: Supporting Ukraine to Prevail, Rebuild, and Prosper

Open Society Foundations Reliefweb OCHA Services (2022) C2

First and foremost, Ukraine’s priority is winning the war and ensuring the safety and security of its people. Ukraine is facing a harsh winter and needs urgent aid and solutions including power generators, heating, and temporary housing to withstand freezing temperatures, ice, and snow. In additio... more

Download (595)

View PDF (301)

Pakistan Humanitarian Response Plan 2021 (April 2021)

Office for the Coordination of Humanitarian Affairs OCHA (2021) C2

Download (745)

View PDF (767)

Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile

World Health Organization World Health Organization WHO (2021) C_WHO

TARGET PRODUCT PROFILE

Download (598)

View PDF (1085)

Diagnostic target product profiles for monitoring, evaluation and surveillance of schistosomiasis control programmes

World Health Organization World Health Organization WHO (2021) C_WHO

Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ... more

Download (592)

View PDF (902)

Broken links Psychosocial support for people separated from family members: a field guide
recommended

International Federation of Red Cross and Red Crescent Societies IFRC (2014) C1

The 40-page field guide outlines possible causes of separation, discusses the psychosocial impacts of being separated, such as how we experience loss, and provides guidelines on how to support those who have been separated from family members – including delivering difficult news to loved ones, ba... more

External Link

Financing Global Health 2014: Shifts in Funding as the MDG Era Closes

Institute for Health Metrics and Evaluation (2015) CC

Financing Global Health 2014 is the sixth edition of this annually produced report on global health financing. As in previous years, this report captures trends in development assistance for health (DAH) and government health expenditure (GHE). Health financing is one of IHME’s core research areas... more

Download (717)

View PDF (1272)

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO

with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden

Download (607)

View PDF (790)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more